Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: A case-control study

Chest

Volumn 139, Issue 1, 2011, Pages 23-27

  Fritscher, Leandro G ^a,c,d   Marras, Theodore K ^a   Bradi, Ana C ^a   Fritscher, Carlos C ^c   Balter, Meyer S ^b   Chapman, Kenneth R ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BECLOMETASONE; CORTICOSTEROID; STEROID;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATYPICAL MYCOBACTERIOSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM XENOPEI; PRIORITY JOURNAL; SPUTUM; TREATMENT DURATION;

EID: 78651429321     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0186     Document Type: Article

References (22)

1. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax. 2007;62(8):661-666.
2. Griffith DE, Aksamit T, Brown-Elliott BA, et al; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367-416.
3. Chanez P, Wenzel SE, Anderson GP, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol. 2007;119(6):1337-1348.
4. Chapman KR. Asthma unresponsive to usual therapy. In: FitzGerald M, ed. Evidence-Based Asthma. London, England : BC Decker Inc; 2001 : 291-305.
5. Atmar RL, Guy E, Guntupalli KK, et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med. 1998;158(22):2453-2459. (Pubitemid 28555504)
6. Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R. Chlamydia pneumoniae and asthma. Thorax. 1998; 53(4):254-259.
7. Gencay M, Rüdiger JJ, Tamm M, Solér M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med. 2001;163(5):1097-1100.
8. Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med. 1998;158(3):998-1001.
9. Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest. 2007;132(6):1962-1966.
10. ten Brinke A, van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF, Bel EH. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol. 2001;107(3):449-454.
11. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143-178.
12. Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002;121(4):1051-1057.
13. Calverley PM, Anderson JA, Celli B, et al; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775-789.
14. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol. 2007;120(6):1233-1244.
15. Middleton AM, Chadwick MV, Nicholson AG, et al. Inhibition of adherence of Mycobacterium avium complex and Mycobacterium tuberculosis to fibronectin on the respiratory mucosa. Respir Med. 2004;98(12):1203-1206.
16. Holt PG, Rowe J, Loh R, Sly PD. Developmental factors associated with risk for atopic disease: implications for vaccine strategies in early childhood. Vaccine. 2003;21(24):3432-3435. (Pubitemid 36792098)
17. Martinez FD. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proc Am Thorac Soc. 2005;2(2):157-161.
18. Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352(20):2082-2090.
19. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med. 2005;172(9):1078-1089.
20. Johnston SL. Macrolide antibiotics and asthma treatment. J Allergy Clin Immunol. 2006;117(6):1233-1236.
21. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J. 2002;19(1):68-75. (Pubitemid 34105570)
22. Wark PA, Johnston SL, Simpson JL, Hensley MJ, Gibson PG. Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur Respir J. 2002;20(4):834-840.